TMCnet News
Vir Biotechnology to Present at 38th Annual J.P. Morgan Healthcare ConferenceSAN FRANCISCO, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, today announced that George Scangos, Ph.D., Chief Executive Officer will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th at 2:00 p.m. PT. A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there following the presentation for 30 days. About Vir Biotechnology Contact: Vir Biotechnology, Inc. Investors Neera Ravindran, MD Head of Investor Relations & Strategic Communications [email protected] +1-415-506-5256 Media Lindy Devereux Scient PR [email protected] +1-646-515-5730 |